Stoke Therapeutics Inc (STOK) Stock Price, Quote, News & History

STOKNASDAQ
$25.88
0.381.49%
At close: Sep 29, 5:00 PM EST
$25.88
N/A
After Hours: 4:00 PM EST

Stoke Therapeutics (STOK) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-177.99M
Investing Cash Flow (TTM)
7.75M
Financing Cash Flow (TTM)
181.70M
Free Cash Flow (TTM)
-180.68M
Capital Expenditure (TTM)
-2.69M
Net Change in Cash (TTM)
11.46M

Analyst Trends and Forecast

1
May
1
Jul
5
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.35B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
57.71
PB Ratio (TTM)
4.76
Earnings Yield % (TTM)
-13.29%
Earnings Yield % (FWD)
-12.98%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.36

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$110.00M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$25.31
Close
$25.88
Volume / Avg.
1.08M / 906.69K
Day Range
$25.12 - $25.99
52 Wk Range
20.32 - 40.22
Market Cap
$1.61B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
18.62%
Days to Cover
17.31

About

Sector
Health Care
Industry
Biotechnology
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antise...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Stoke Therapeutics (STOK) stock?

A

You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Stoke Therapeutics (STOK) competitors?

Q

What is the forecast, or price target, for Stoke Therapeutics (STOK) stock?

A

Stoke Therapeutics has a consensus price target of $41.15.

Q

What is the current price for Stoke Therapeutics (STOK)?

A

The stock price for Stoke Therapeutics (NASDAQ: STOK) is $25.88 last updated September 29, 2026 at 4:00 PM EDT.

Q

Does Stoke Therapeutics (STOK) pay a dividend?

A

There are no upcoming dividends for Stoke Therapeutics.

Q

When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?

A

Stoke Therapeutics does not have any upcoming earnings scheduled.

Q

Is Stoke Therapeutics (STOK) going to split?

A

There is no upcoming split for Stoke Therapeutics.

Q

What sector and industry does Stoke Therapeutics (STOK) operate in?

A

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.